Lung cancerMACA CANCER INFORMATION GUIDE

Understanding lung cancer.

What lung cancer is, the signs to look out for, how it is diagnosed and staged, and the treatments your care team may discuss with you.

What is lung cancer?

Lung cancer is a disease that begins in the cells of the lungs. Like other types of cancer, it occurs when cells grow and divide uncontrollably, forming tumours that can spread to other parts of the body.

Each type of cancer is named after the cells where it starts. Cancer that begins somewhere else and spreads to the lungs is not lung cancer: liver cancer that spreads to the lungs, for example, is still liver cancer.

How the lungs work

The lungs are the main organs of the respiratory system. Their job is to exchange gases: bringing oxygen into the body and removing carbon dioxide. Every cell in the body needs oxygen, and the lungs pass it from the air you breathe into the bloodstream. At the same time they remove carbon dioxide, a waste product made by cells, and release it as you breathe out.

When you breathe in, air travels through the throat into the windpipe (trachea), which divides into two tubes called bronchi, one for each lung. The bronchi branch into smaller tubes called bronchioles, which end in tiny air sacs called alveoli. The alveoli are surrounded by blood vessels, and this is where oxygen and carbon dioxide are exchanged.

The right lung has three sections, called lobes, and the left lung has two. Each lobe receives air from a branch of the bronchial tree.

The pleura and lymph nodes

The lungs are protected by a thin lining called the pleura, which has two layers:

  • Parietal pleura: the outer layer.
  • Visceral pleura: the inner layer that covers the lungs.

Between the two layers is the pleural cavity, which holds a small amount of fluid that helps the lungs move smoothly as you breathe. In lung cancer, cancer cells are sometimes found in this pleural fluid.

A clear fluid called lymph flows through vessels and lymph nodes throughout the body, nourishing cells and helping the immune system fight infection. In the lungs, lymph nodes lie along the bronchi and connect to nodes near the trachea and in the neck. Cancer can start in or spread to these lymph nodes.

Signs and symptoms

The symptoms of lung cancer can come from the tumour itself, from its growth and spread within the chest, from spread to other parts of the body, or from effects on the whole body that are not caused directly by the tumour (paraneoplastic syndromes), such as fever or other unexpected changes in how the body works.

Common symptoms

The most frequent symptom of lung cancer is a cough that does not go away. Other common signs include:

  • Shortness of breath (dyspnoea)
  • Coughing up blood (haemoptysis)
  • Chest pain
  • Tiredness (fatigue)
  • Weight loss without trying
  • Fever

When the tumour affects nearby tissues

  • Swollen lymph nodes, especially in the neck
  • Shoulder, arm or chest pain, often because a nerve is affected
  • Hoarseness or difficulty speaking, which can happen if a vocal cord is paralysed
  • Difficulty swallowing, if the tumour presses on the food pipe (oesophagus)

When the cancer has spread

If lung cancer spreads, symptoms depend on where it has spread to. Spread to the brain can cause neurological symptoms, and spread to the bones can cause bone pain or fractures.

When there are no symptoms

Sometimes lung cancer causes no symptoms at all and is found by chance, when a chest X-ray or CT scan done for another reason shows a lung nodule. Further tests are then needed to find out whether the nodule is cancer.

Risk factors

Smoking

Smoking tobacco is the leading risk factor for lung cancer. The more a person smokes and the longer they smoke, the higher their risk. Quitting lowers the risk over time, although former smokers still have a higher risk than people who have never smoked. Breathing in other people’s smoke (second-hand smoke) also increases the risk, even in non-smokers.

Radon and uranium

Uranium, a natural substance found in rocks and soil, can cause lung cancer, especially in uranium miners. As uranium breaks down it releases radon gas, which can seep into air and water and build up indoors, particularly in poorly ventilated buildings and basements. The risk rises with higher radon levels and longer exposure.

Harmful substances

Long-term exposure to certain substances, often at work, also raises the risk:

  • Asbestos
  • Arsenic
  • Beryllium
  • Cadmium
  • Chromium
  • Nickel
  • Silica
  • Diesel exhaust
  • Coal smoke and soot

Existing lung conditions

  • Chronic obstructive pulmonary disease (COPD)
  • Pulmonary fibrosis, a condition that scars the lung tissue

Family history

People with a family history of lung cancer, especially when several relatives have been affected, may be at higher risk, particularly if they also smoke.

Other cancers

People who have had other smoking-related cancers have a higher risk of lung cancer. These include cancers of the stomach, bladder, kidney, pancreas and cervix, head and neck cancers and acute myeloid leukaemia. People who have had lymphoma may also be at increased risk.

Types of lung cancer

Nearly all lung cancers are carcinomas, meaning they start in epithelial cells, the cells lining the surface of the airways. They are divided into two main groups based on how the cancer cells look under a microscope:

  • Non-small cell lung cancer (NSCLC): the most common type, about 85–90% of lung cancers. Its main subtypes are:
    • Adenocarcinoma, about 40% of lung cancers
    • Squamous cell carcinoma, about 25–30%
    • Large cell carcinoma, about 10–15%
    • Rarer types, such as adenosquamous and sarcomatoid carcinoma
  • Small cell lung cancer (SCLC): about 10–15% of lung cancers. It is more aggressive and tends to grow and spread faster than NSCLC.

Knowing the type matters because NSCLC and SCLC behave differently and are treated differently.

Diagnosis

To diagnose lung cancer and find out how far it has spread, doctors use several types of tests.

Medical history and lifestyle

The first step is a detailed conversation with your doctor about your current symptoms, past health problems and treatments, any family history of cancer, and whether you have smoked, how much and for how long. Your answers help your doctor decide which tests to do next.

Physical examination

Your doctor will listen to your lungs and heart, measure your temperature, blood pressure, weight and breathing rate, and check your overall health. They will also assess how well you manage everyday activities (your performance status), which helps show how fit you are for treatment.

Laboratory tests

  • Full blood count: looks at red and white blood cells and platelets.
  • Biochemistry profile: checks how well your kidneys, liver and bones are working.
  • Biomarker tests: tests on the tumour sample that look for changes in genes such as EGFR or ALK, which help guide treatment.

Imaging tests

  • CT scan: detailed images of the lungs and other organs.
  • PET scan: shows areas of active cancer.
  • PET-CT scan: combines both for more precise results.
  • MRI scan: especially useful for checking the brain or spine.

Taking samples of tissue or fluid

Lung cancer can only be confirmed by looking at cells under a microscope. Samples can be taken by:

  • Biopsy: removing a small piece of lung tissue.
  • Cytology: taking fluid or cells with a thin needle.
  • Bronchoscopy: passing a thin camera into the airways to look inside and take samples.
  • Mediastinoscopy: a small operation to take samples from lymph nodes in the chest.

These tests show the type of lung cancer and how far it has spread.

Stages and outlook

Staging describes how far the cancer has spread and is essential for planning treatment. Doctors usually diagnose and stage lung cancer at the same time, using imaging, biopsies and other tests.

The TNM system

  • T (tumour): the size and location of the main tumour.
  • N (nodes): whether the cancer has spread to nearby lymph nodes.
  • M (metastasis): whether it has spread to distant parts of the body.

Together these give an overall stage from 0 to IV:

  • Occult carcinoma: cancer cells are found in lung fluid or mucus, but no tumour can be seen.
  • Stage 0 (in situ): cancer cells are in the lining of the airway but have not grown into deeper tissue.
  • Stages I–III: the cancer has grown into lung tissue and may have spread to nearby lymph nodes.
  • Stage IV: the cancer has spread to distant organs or tissues.

How common is lung cancer?

Lung cancer is one of the most commonly diagnosed cancers in the world and the leading cause of cancer deaths. It accounts for about 17% of all cancers in men and 9% in women. Rates are often higher in higher-income countries, and in some places they are falling in men but rising in women, largely because of past smoking patterns.

Outlook

A person’s outlook depends on their age and sex, lung function, other health conditions, the type and subtype of cancer, the stage at diagnosis and the treatment they receive.

  • Localised lung cancer: that has not spread beyond the lung has the best outlook, with a five-year survival rate of about 58%.
  • Regional lung cancer: that has spread to nearby lymph nodes has a moderate outlook.
  • Distant (metastatic) lung cancer: that has spread to organs such as the brain, liver or bones has the lowest survival rates.

NSCLC generally has a better outlook than SCLC, which progresses more quickly and is more often diagnosed at an advanced stage. These figures describe large groups of people; your care team can explain what they mean for you.

Treatment

Treatment depends on the type of lung cancer (NSCLC or SCLC), its stage, any biomarkers found in the cancer cells and your general health. Once the diagnosis and stage are confirmed, your doctors will suggest a treatment plan made for you. The main (primary) treatment aims to remove or destroy the cancer and may combine surgery, radiotherapy, chemotherapy and immunotherapy.

Surgery

Surgery is mainly used for early-stage NSCLC that has not spread far. The surgeon removes the tumour, some healthy tissue around it to make sure no cancer is left, and nearby lymph nodes, which are checked under a microscope for spread. Surgery is not usually used for SCLC, because it tends to spread quickly.

Chemotherapy and chemoradiotherapy

Chemotherapy uses medicines to kill cancer cells throughout the body. It is often used when the cancer has spread beyond the lung, or alongside other treatments such as radiotherapy. Cisplatin, usually combined with other medicines, is commonly used.

Chemoradiotherapy combines chemotherapy and radiotherapy, especially for NSCLC that has spread within the chest. Afterwards some people receive durvalumab, an immunotherapy that helps keep the cancer under control. Side effects can include tiredness, nausea, a sore throat, cough and shortness of breath.

Radiotherapy

Radiotherapy uses high-energy rays to destroy cancer cells in the lungs. It is used when surgery is not possible or not safe, and with chemotherapy to make treatment more effective. Cancer cells outside the area being treated may need chemotherapy.

Immunotherapy

Immunotherapy helps your immune system recognise and destroy cancer cells. Some cancers make proteins such as PD-L1 that hide them from immune cells. Medicines called checkpoint inhibitors block this, so the immune system can attack the cancer. They are used for specific types of lung cancer, especially those with high levels of PD-L1.

Small cell lung cancer

SCLC is usually treated with chemotherapy and radiotherapy rather than surgery. Because SCLC often spreads to the brain, some people are offered prophylactic cranial irradiation (PCI), radiotherapy to the brain that lowers the chance of it spreading there.

Clinical trials

Clinical trials are research studies that test whether a new treatment, a new combination of treatments or a new way of giving an existing treatment works better than current care. Many of today’s standard treatments were first offered through clinical trials.

What taking part involves

  • Every trial has eligibility criteria, such as the type and stage of cancer, previous treatment and general health.
  • Trials must be approved by a research ethics committee and, for medicines, by the national regulator. In Nigeria this includes NAFDAC and a recognised health research ethics committee.
  • You will be given written information and asked for your informed consent before you join. You can ask questions at any time.
  • Taking part is voluntary. You can leave a trial at any point and still receive standard care.

Finding a trial

Your treating team is the best place to start, because they know your diagnosis and which trials could suit you. Trial registries list studies that are recruiting:

  • Pan African Clinical Trials Registry (PACTR): trials taking place in African countries.
  • WHO International Clinical Trials Registry Platform: one search across registries worldwide.
  • ClinicalTrials.gov: a large international registry run by the US National Library of Medicine.

Living with and after treatment

Side effects

All treatments can cause side effects, which may include:

  • Tiredness (fatigue)
  • Nausea or vomiting
  • Breathing difficulties
  • A sore throat or mouth
  • A weakened immune system and a higher risk of infection

Your doctors will help you manage these effects and may adjust treatment to reduce discomfort. Tell your team about any new or worsening symptom, especially fever, chest pain or increasing breathlessness.

Follow-up

After treatment you will have regular check-ups and scans to look for any sign of the cancer returning and to help you recover. Breathing exercises, staying as active as you can and good nutrition all support recovery.

Questions to ask your care team

  • What type of lung cancer do I have, and what stage is it?
  • Has my tumour been tested for biomarkers such as EGFR, ALK or PD-L1?
  • What are my treatment options, and what is the aim of each one?
  • What side effects should I expect, and who do I contact if I have them?
  • Is there a clinical trial that could be right for me?
  • What support is available to help me stop smoking?

LET’S KEEP THE CONVERSATION GOING

Understanding grows
when we come together.

Connect with MACA